A phase 1 study of Resunab in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 28 Sep 2016
At a glance
- Drugs Ajulemic acid (Primary)
- Indications Cystic fibrosis; Scleroderma
- Focus Adverse reactions; Pharmacokinetics
- 28 Sep 2016 According to Corbus Pharmaceticals media release, data from this study was presented at 6th European Workshop on Lipid Mediators at Goethe University in, Germany.
- 28 Sep 2016 Results were published in Corbus Pharmaceuticals Media Release.
- 21 Aug 2015 New trial record